Bioidentical hormone treatments are the safest known treatments for osteoporosis for both male and females.
One out of 12 men suffer from osteoporosis
When we speak of osteoporosis, it is usually associated with females. It is no longer surprising when older women develop osteoporosis or porous bone mass. It is quite different, though, when men acquire this condition. Many people believe that osteoporosis is a health condition exclusive to females. Little is it known that one out of 12 men suffer from osteoporosis.
Osteoporosis is a medical condition resulting from very low estrogen levels in the body. Since estrogen is essentially a female hormone, it is easy to assume that osteoporosis is a disease that only women can acquire. The truth, however, is that males too manufacture estrogen hormones in their bodies. Studies show that estrogen in males may even be a more important hormone than testosterone for the maintenance of bone density.
Testosterone hormones are responsible for the larger size and thicker outer layer of male bone structure. Estrogen, on the other hand, is the key hormone that maintains bone mineral mass.
In a research conducted at Washington University School of Medicine in St. Louis, it was leant that extremely low amounts of active estrogen metabolites in men increases the risk of osteoporosis.
Active estrogen metabolites are a strong predictor of bone mineral density in males. When men have higher levels of active estrogen metabolites, they also have higher bone density. Conversely, men with lower levels of these hormones tend to have brittle bones.
Bioidentical hormones to promote bone mass
Bone mass for both men and women peak at the age of 20s and slowly decline thereafter. As time passes, small cracks develop around the bones. Cells called osteoclasts, remove the damaged bone. Repair cells called osteoblasts then repair the hole. While estrogen slows the rate at which the osteoclasts removes the damaged bone, progesterone and testosterone stimulate the osteoblasts to repair and build new bone.
When men grow older, not only do their testosterone levels decline but also their estrogen production. The result of which is that bone loss speeds up. Bones damaged by osteoporosis may never be fully repaired.
In conditions like this, patients are recommended to undergo bioidentical hormone treatment. By balancing hormone levels through bioidentical hormone treatment, bone loss is prevented.
What is bioidentical hormone treatment?
Bioidentical hormone treatment is a form of medication using hormones that are identical to those produced by the body. These hormones are taken from plant substances and transformed into human-like hormones. They are safe and have no proven side effects when used as prescribed. They are an effective treatment for hormone deficiency that often leads to osteoporosis.
In dealing with osteoporosis, bioidentical hormone treatments are the most effective medications.
Bioidentical hormone treatments maybe composed of any of the estrogen, progesterone or testosterone hormones. They may be bought in ready-made standard dosages or maybe compounded in compounding pharmacies. The dosages for each of the hormones used is usually measured according to the actual hormonal deficiency.
In dealing with osteoporosis, bioidentical hormone treatments are the most effective medications. They duplicate and augment for human hormone loss which is often the core cause of osteoporosis.
Osteoporosis can be a silent and deadly disease, which often lies undiscovered for a long time. Not only is this in itself a dangerous condition, the fatality rate associated with osteoporosis-related fractures is shockingly high! Raloxifene can drastically reduce these risks by preventing and treating osteoporosis in postmenopausal women. It helps preserve and increase bone mass and has been proven to significantly reduce the risk of fractures. And unlike hormone-based medication, Raloxifene is a lot less prone to negative side effects. You might be getting a little older, but your bones don’t have to.
